购物车
- 全部删除
- 您的购物车当前为空
Carboxyamidotriazole Orotate (L-651582 Orotate) 是一种可口服的信号转导抑制剂,是Carboxyamidotriazole (CAI) 的乳清酸盐形式。它是一种非电压性钙通道和钙通道介导的信号通路的细胞抑制剂,具有抗癌、抗炎活性和抗血管生成作用。
Carboxyamidotriazole Orotate (L-651582 Orotate) 是一种可口服的信号转导抑制剂,是Carboxyamidotriazole (CAI) 的乳清酸盐形式。它是一种非电压性钙通道和钙通道介导的信号通路的细胞抑制剂,具有抗癌、抗炎活性和抗血管生成作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 538 | 现货 | |
5 mg | ¥ 1,320 | 现货 | |
10 mg | ¥ 1,990 | 现货 | |
25 mg | ¥ 3,380 | 现货 | |
50 mg | ¥ 4,790 | 现货 | |
100 mg | ¥ 6,720 | 现货 |
产品描述 | Carboxyamidotriazole Orotate (L-651582 Orotate) is a cytostatic inhibitor of non-voltage-operated calcium channels and calcium channel-mediated signaling pathways. Carboxyamidotriazole Orotate (L-651582 Orotate) is the orotate salt form of Carboxyamidotriazole (CAI), an orally bioavailable signal transduction inhibitor that in vitro has been shown to possess antileukaemic activities. Carboxyamidotriazole Orotate shows anti-tumor, anti-inflammatory, and antiangiogenic effects. |
体外活性 | Carboxyamidotriazole Orotate 抑制 Bcr-Abl 激酶的特定靶标磷酸化作用。在0.1-10 μM浓度范围内,持续24-96小时的 Carboxyamidotriazole Orotate 处理可抑制 LAMA84R 和 K562R 细胞系的细胞增殖[1]。5 μM Carboxyamidotriazole Orotate 处理还能减少 CrkL 的酪氨酸磷酸化水平[1]。 |
体内活性 | 在CML异种移植瘤上,Carboxyamidotriazole Orotate(342, 513 mg/kg;i.p.;Q1D×5,进行两轮)展现了抗肿瘤活性[1]。 |
别名 | L-651582 Orotate, CAI Orotate |
分子量 | 580.76 |
分子式 | C22H16Cl3N7O6 |
CAS No. | 187739-60-2 |
Smiles | OC(=O)c1cc(=O)[nH]c(=O)[nH]1.NC(=O)c1nnn(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)c1N |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
溶解度信息 | DMSO: 5 mg/mL (8.61 mM), Sonication is recommended. | |||||||||||||||
溶液配制表 | ||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容